0001140361-16-078629.txt : 20160902
0001140361-16-078629.hdr.sgml : 20160902
20160902123753
ACCESSION NUMBER: 0001140361-16-078629
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160901
FILED AS OF DATE: 20160902
DATE AS OF CHANGE: 20160902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Relypsa Inc
CENTRAL INDEX KEY: 0001416792
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260893742
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-421-9500
MAIL ADDRESS:
STREET 1: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schuetz Thomas J.
CENTRAL INDEX KEY: 0001591464
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36184
FILM NUMBER: 161867860
MAIL ADDRESS:
STREET 1: C/O RELYPSA, INC.
STREET 2: 700 SAGINAW DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc1.xml
FORM 4
X0306
4
2016-09-01
1
0001416792
Relypsa Inc
RLYP
0001591464
Schuetz Thomas J.
C/O RELYPSA, INC.
100 CARDINAL WAY
REDWOOD CITY
CA
94063
1
0
0
0
Common Stock
2016-09-01
4
U
0
33962
32.00
D
2250
D
Common Stock
2016-09-01
4
D
0
2250
32.00
D
0
D
Stock Option (Right to Buy)
4.65
2016-09-01
4
D
0
6976
D
2020-09-28
Common Stock
6976
0
D
Stock Option (Right to Buy)
4.65
2016-09-01
4
D
0
581
D
2020-11-29
Common Stock
581
0
D
Stock Option (Right to Buy)
4.65
2016-09-01
4
D
0
1744
D
2021-03-30
Common Stock
1744
0
D
Stock Option (Right to Buy)
4.65
2016-09-01
4
D
0
872
D
2021-06-08
Common Stock
872
0
D
Stock Option (Right to Buy)
3.96
2016-09-01
4
D
0
15697
D
2021-09-13
Common Stock
15697
0
D
Stock Option (Right to Buy)
3.96
2016-09-01
4
D
0
9011
D
2022-09-27
Common Stock
9011
0
D
Stock Option (Right to Buy)
7.40
2016-09-01
4
D
0
10140
D
2023-07-23
Common Stock
10140
0
D
Stock Option (Right to Buy)
23.96
2016-09-01
4
D
0
3828
D
2024-06-18
Common Stock
3828
0
D
Stock Option (Right to Buy)
35.79
2016-09-01
4
D
0
4500
D
2025-06-03
Common Stock
4500
0
D
Stock Option (Right to Buy)
17.00
2016-09-01
4
D
0
4500
D
2026-06-20
Common Stock
4500
0
D
Pursuant to the terms of the Agreement and Plan of Merger, dated as of July 20, 2016 (the "Merger Agreement"), by and among the Issuer, Galencia AG, a public limited company existing under the laws of Switzerland ("Parent"), and Vifor Pharma USA Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent, on September 1, 2016, shares disposed of in exchange for cash consideration of $32.00 per share, without interest, subject to any applicable withholding taxes.
Pursuant to the terms of the Merger Agreement, on September 1, 2016, each award of restricted stock units and stock options was cancelled in exchange for the right to receive $32.00 per share in cash less any applicable withholding taxes and in the case of stock options, less the applicable exercise price.
Pursuant to the terms of the Merger Agreement, on September 1, 2016, the stock option was cancelled and no cash payment was made as the exercise price exceeded $32.00 per share.
/s/ Ronald A. Krasnow, as Attorney-in-Fact for Thomas J. Schuetz
2016-09-02